Director of Thoracic Oncology at Georgetown University @Lombardicancer / Lung Cancer, Thymic Tumors, Phase I / #SoMeEditor @ClinicalLung / Secretary of ITMIG
Washington, DC
Joined February 2017
- Tweets4K
- Following920
- Followers3.8K
- Likes23.8K
Chul Kim retweeted
#ESMO26 | PERSEE – Phase III
In advanced NSCLC with PD-L1 ≥50%, adding chemotherapy to pembrolizumab improved median PFS from 6.9 to 16.1 months (HR 0.56). The numerical OS difference was notable (50.2 vs 29.9 months; HR 0.77), but not statistically significant. However, we should remember that OS was not the primary endpoint!
Grade ≥3 toxicity: 53.8% vs 19.3%.
I think adding chemotherapy provides benefit, but at the cost of increased toxicity. We need to better identify the patients for whom this toxicity is worth it.
Chul Kim retweeted
Join us to reimagine, revolutionize cancer care and cancer research in the State of Louisiana, starting at the hub at New Orleans to impact the cancer outcomes statewide in LA. NOLA offers Amazing work-life balance, with tons of sunshine, rich cultures, warm hospitality, unending cuisines, Mardi gras and Jazz, great urban fun and wonderful suburban communities. DM or email with questions or interest: [email protected] nam10.safelinks.protection.o…
Chul Kim retweeted
The news about Pope Leo XIV’s lung cancer diagnosis caught my attention. As a lung cancer physician, I know the gravity a diagnosis like this can have on a patient and the people who care about them.
Read more: linkedin.com/posts/roy-herbs…
@DartmouthCancer @DartmouthHealth
Chul Kim retweeted
Thrilled and honored to receive the 2026 Career Development Award from @LC_Initiative_ ! Our project, TRACE-SCLC, will test whether an ultrasensitive, tumor-informed blood test can detect progression in ES-SCLC before scans do. Excited to get started!
@SclcSMASHERS @DukeCancer @DukeHealth
Chul Kim retweeted
I would like to thank all those who have prayed for me in recent days. I wish to express my particular gratitude to the doctors, nurses and all the staff of the Gemelli Hospital. This experience has made me feel particularly close to all those who are living with illness or infirmity. Now that I have overcome this delicate phase I will gradually resume my activities, always with God’s help and your prayers.
Chul Kim retweeted
Pope Leo XIV already well on the road to recovery from his lung cancer surgery. I talked to @NewsCentralCNN about what we know and what we still need to know about the results for @Pontifex. We remain extremely optimistic about the path forward.
video.snapstream.net/Play/3b…
Chul Kim retweeted
Report from LIGHT-NING Study: Japanese real world nivolumab + ipilimumab for NSCLC @ClinicalLung. With chemo, OS 21.7m, PFS 6.8m and without chemo, OS 18.8m, PFS 6.3m. G3+ treatment related AEs seen in 53% (with chemo) and 31% (without chemo).
clinical-lung-cancer.com/art…
Chul Kim retweeted
Great summary about @Pontifex and lung cancer from @StephenVLiu. Still a lot ahead - recovery, staging, molecular testing - but sounds like a good start!
video.snapstream.net/Play/3b…
Chul Kim retweeted
Pope Leo XIV has been diagnosed with lung adenocarcinoma.
While we had hoped for a different diagnosis, the fact that he was able to undergo a lobectomy is encouraging. Surgery is generally pursued when lung cancer appears localized and potentially curable.
Final pathology will help determine prognosis and whether additional treatment is needed.
Wishing the Holy Father a smooth and speedy recovery.
lombardi.georgetown.edu/lomb…
Chul Kim retweeted
Congratulations to @StephenVLiu & @Joshua_Reuss for an outstanding #DCLung26 and a marvelous first DC Lung Prom!! 💃🕺
A day of terrific presentations and insightful conversations. I was honored to present on initial treatment of ES-SCLC!
Finished the day by celebrating our amazing 🫁 community with Lung Prom!! All proceeds directly supported @LUNGevity Foundation, dedicated to advancing lung cancer research and supporting those affected by the disease.
@drshieldsmd @maraantonoff @Latinamd @jennifermarksmd @JuliaRotow @NaglaAKarimMD @chulkimMD @lungoncdoc @LUNGevity @SclcSMASHERS
Calling early-career physicians across all disciplines!
The @IASLC Academy, led by Drs. @JairBar4 and @ZPiotrowskaMD, offers mentorship, career development, global networking.
Eligible: Within 6 years of starting faculty career.
Deadline: 11/1/2026
bit.ly/3VFUEQ6
Chul Kim retweeted
A few interesting things I learned at #DCLung26🫁
• Negative LB w/ ctDNA TF <1%: Prioritize tissue NGS (Rolfo, CCR 2024)
• METex14 NSCLC w/ PD-L1 >80%: 1L ICI ± chemo may outperform MET TKI (Pecci, CCR 2025)
• Thymic health is associated with ICI outcomes and OS (Bernatz, Nature 2026)
Chul Kim retweeted
An amazing weekend at #DCLung26! Great science and even greater people. Feeling so blessed to be part of this community.
Loved exploring DC, catching the Tony-winning musical Maybe Happy Ending, and reconnecting with dear friends😁
Heading back to Houston with so many new ideas!💡
Chul Kim retweeted
Thymic health matters!
Intriguing discussion by @chulkimMD at #DCLung26 on TET and thymic health in NSCLC patients
@StephenVLiu @Joshua_Reuss
Chul Kim retweeted
Looking forward to learning the latest on #lungcancer research. And, did I mention I’ll open the conference talking about “My life with cancer” :) 🎤🫁 🔬
Join us in Washington, DC tomorrow, Saturday, October 10 for #DCLung26 - a 1-day, comprehensive, @IASLC endorsed, multidisciplinary, discussion-based lung cancer CME update!
On-site registration available and join us afterwards for our inaugural gala!
medstarhealth.org/dclung
Chul Kim retweeted
Dr. @BrendonStilesMD discusses the role of surgery in mesothelioma as of 2026.
“I knew this panel invite was a setup.” 🤣
#DCLung26
Chul Kim retweeted
#DCLung26 @ChristianRolfo @OSUCCC_James discusses the next generation of immunotherapies in lung cancer—from bispecifics to trispecifics. Exciting advances ahead! #LungCancer #ThoracicOncology #lcsm
